Taken together, these data demonstrate that the IL-6/STAT3 signaling pathway plays an important role in depression or depression-like behavious, and targeting this pathway may provide a novel therapeutic approach for the treatment of this disorder. Here, STAT3 is linked to depressive symptom measurement.